• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于免疫炎症的指数的开发和验证,用于预测鼻咽癌患者的临床结局。

Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.

机构信息

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

出版信息

J Cell Mol Med. 2020 Aug;24(15):8326-8349. doi: 10.1111/jcmm.15097. Epub 2020 Jun 30.

DOI:10.1111/jcmm.15097
PMID:32603520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7412424/
Abstract

Inflammation indicators, such as systemic inflammation response index (SIRI), systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), are associated with poor prognosis in various solid cancers. In this study, we investigated the predictive value of these inflammation indicators in nasopharyngeal carcinoma (NPC). This retrospective study involved 559 patients with NPC and 500 patients with chronic rhinitis, and 255 NPC patients were followed up successfully. Continuous variables and qualitative variables were measured by t test and chi-square test, respectively. The optimal cut-off values of various inflammation indicators were determined by receiver operating characteristic (ROC) curve. Moreover, the diagnostic value for NPC was decided by the area under the curves (AUCs). The Kaplan-Meier methods and the log-rank test were used to analyse overall survival (OS) and disease-free survival (DFS). The independent prognostic risk factors for survival and influencing factors of side effects after treatment were analysed by Cox and logistic regression analysis, respectively. Most haematological indexes of NPC and rhinitis were significantly different between the two groups, and PLR was optimal predictive indicators of diagnosis. In the multivariable Cox regression analysis, PLR, WBC, RDW, M stage and age were independent prognostic risk factors. Many inflammation indicators that affected various side effects were evaluated by logistic regression analysis. In conclusion, the combined inflammation indicators were superior to single haematological indicator in the diagnosis and prognosis of NPC. These inflammation indicators can be used to supply the current evaluation system of the TNM staging system to help predict the prognosis in NPC patients.

摘要

炎症指标,如全身炎症反应指数(SIRI)、全身免疫炎症指数(SII)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR),与各种实体瘤的预后不良相关。在本研究中,我们调查了这些炎症指标在鼻咽癌(NPC)中的预测价值。这项回顾性研究涉及 559 例 NPC 患者和 500 例慢性鼻炎患者,其中 255 例 NPC 患者成功随访。连续变量和定性变量分别通过 t 检验和卡方检验进行测量。通过接收者操作特征(ROC)曲线确定各种炎症指标的最佳截断值。此外,曲线下面积(AUCs)决定了对 NPC 的诊断价值。Kaplan-Meier 方法和对数秩检验用于分析总生存期(OS)和无病生存期(DFS)。通过 Cox 和逻辑回归分析分别分析生存的独立预后危险因素和治疗后副作用的影响因素。NPC 和鼻炎两组的大多数血液学指标差异显著,PLR 是诊断的最佳预测指标。在多变量 Cox 回归分析中,PLR、WBC、RDW、M 分期和年龄是独立的预后危险因素。通过逻辑回归分析评估了许多影响各种副作用的炎症指标。总之,联合炎症指标在 NPC 的诊断和预后方面优于单一血液学指标。这些炎症指标可用于补充当前的 TNM 分期系统评估体系,以帮助预测 NPC 患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/4e8cabb0772a/JCMM-24-8326-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/0765a46cf2d8/JCMM-24-8326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/c90c30be1ccf/JCMM-24-8326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/c35d6baa9ff8/JCMM-24-8326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/7e9834980a64/JCMM-24-8326-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/92fceab73db6/JCMM-24-8326-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/f68f60e28eed/JCMM-24-8326-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/4e8cabb0772a/JCMM-24-8326-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/0765a46cf2d8/JCMM-24-8326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/c90c30be1ccf/JCMM-24-8326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/c35d6baa9ff8/JCMM-24-8326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/7e9834980a64/JCMM-24-8326-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/92fceab73db6/JCMM-24-8326-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/f68f60e28eed/JCMM-24-8326-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c97d/7412424/4e8cabb0772a/JCMM-24-8326-g007.jpg

相似文献

1
Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.基于免疫炎症的指数的开发和验证,用于预测鼻咽癌患者的临床结局。
J Cell Mol Med. 2020 Aug;24(15):8326-8349. doi: 10.1111/jcmm.15097. Epub 2020 Jun 30.
2
Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.联合预处理中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值预测非转移性鼻咽癌患者的生存和预后:一项回顾性研究。
Sci Rep. 2024 Apr 30;14(1):9898. doi: 10.1038/s41598-024-59131-2.
3
High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations.高表达的 NLR 和 SII 可作为鼻咽癌患者潜在的预后观察指标。
Cancer Control. 2024 Jan-Dec;31:10732748241288106. doi: 10.1177/10732748241288106.
4
The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.调强放疗前后中性粒细胞与淋巴细胞比值对鼻咽癌患者的预后价值
Medicine (Baltimore). 2020 Jan;99(2):e18545. doi: 10.1097/MD.0000000000018545.
5
Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.基于随机生存森林建立的甘油三酯-炎症评分预测鼻咽癌患者生存:一项回顾性研究。
Front Immunol. 2024 Apr 26;15:1375931. doi: 10.3389/fimmu.2024.1375931. eCollection 2024.
6
A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.一种基于炎症的新型分期(I期)可预测鼻咽癌患者的总生存期。
Int J Mol Sci. 2016 Nov 15;17(11):1900. doi: 10.3390/ijms17111900.
7
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.
8
Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.免疫治疗相关炎症指标的预测价值:免疫检查点抑制剂治疗鼻咽癌患者的动态变化。
Ann Med. 2023;55(2):2280002. doi: 10.1080/07853890.2023.2280002. Epub 2023 Dec 8.
9
Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.回顾性研究一种新型血液学参数,用于预测鼻咽癌患者的生存情况。
PeerJ. 2024 Jun 21;12:e17573. doi: 10.7717/peerj.17573. eCollection 2024.
10
Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.中性粒细胞与淋巴细胞比值和单核细胞与嗜酸性粒细胞比值作为晚期鼻咽癌的预后指标。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1971-1989. doi: 10.1007/s00405-024-08474-7. Epub 2024 Feb 5.

引用本文的文献

1
Systemic immune-inflammation index and serum lactate dehydrogenase predict the prognosis of non-metastatic nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.全身免疫炎症指数和血清乳酸脱氢酶可预测接受调强放疗的非转移性鼻咽癌患者的预后。
Sci Rep. 2025 Aug 13;15(1):29715. doi: 10.1038/s41598-025-14455-5.
2
Global trends in sarcopenia and cancer over the past 10 years: a bibliometric analysis.过去10年肌肉减少症与癌症的全球趋势:一项文献计量分析。
Discov Oncol. 2025 Jul 17;16(1):1358. doi: 10.1007/s12672-025-03185-9.
3
A New Perspective on NSTE-ACS Patients in the Emergency Department: Cardiac Risk Prediction with New Inflammation Markers.

本文引用的文献

1
Therapeutic targeting of trained immunity.训练免疫的治疗靶向。
Nat Rev Drug Discov. 2019 Jul;18(7):553-566. doi: 10.1038/s41573-019-0025-4.
2
Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.术前全身免疫炎症指数可预测口腔鳞状细胞癌患者根治性切除术后的预后。
J Transl Med. 2018 Dec 18;16(1):365. doi: 10.1186/s12967-018-1742-x.
3
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
急诊科非ST段抬高型急性冠脉综合征患者的新视角:利用新型炎症标志物进行心脏风险预测
Med Sci Monit. 2025 Jul 2;31:e948699. doi: 10.12659/MSM.948699.
4
Systemic Inflammatory Biomarkers in Alopecia Areata: The Role of SII, SIRI, and CRP/Albumin Ratio.斑秃中的全身炎症生物标志物:全身免疫炎症指数、全身炎症反应指数及C反应蛋白/白蛋白比值的作用
Dermatol Pract Concept. 2025 Apr 1;15(2):4962. doi: 10.5826/dpc.1502a4962.
5
The Relationship Between Preoperative Neutrophil-Lymphocyte Ratio and Postoperative Length of Stay in Carotid Body Tumor Resection.颈动脉体瘤切除术中术前中性粒细胞与淋巴细胞比值与术后住院时间的关系
Int J Genomics. 2025 Apr 23;2025:5431545. doi: 10.1155/ijog/5431545. eCollection 2025.
6
A Novel Inflammation-Marker-Based Prognostic Model for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma.一种基于新型炎症标志物的晚期肺淋巴上皮瘤样癌预后模型。
J Inflamm Res. 2025 Feb 20;18:2433-2445. doi: 10.2147/JIR.S502286. eCollection 2025.
7
Anti-inflammatory diets might mitigate the association between sedentary behaviors and the risk of all-cause deaths.抗炎饮食可能会减轻久坐行为与全因死亡风险之间的关联。
Nutr Metab (Lond). 2025 Feb 14;22(1):11. doi: 10.1186/s12986-025-00907-2.
8
A prognostic nomogram for patients with III-IV nasopharyngeal carcinoma based on dynamic changes in the inflammatory and nutrition index.基于炎症和营养指标动态变化的Ⅲ-Ⅳ期鼻咽癌患者预后列线图
Clin Transl Oncol. 2025 Jun;27(6):2638-2650. doi: 10.1007/s12094-024-03781-1. Epub 2024 Nov 12.
9
Prognostic Value of Pre-Chemoradiotherapy Pan-Immune-Inflammation Value (PIV) in Locally Advanced Nasopharyngeal Cancers.局部晚期鼻咽癌患者放化疗前的 Pan-Immune-Inflammation 值的预后价值。
Cancer Control. 2024 Jan-Dec;31:10732748241290746. doi: 10.1177/10732748241290746.
10
A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma.基于炎症和营养指标的评分系统预测非转移性鼻咽癌患者的长期生存。
Sci Rep. 2024 Aug 30;14(1):20229. doi: 10.1038/s41598-024-71360-z.
鉴定和验证头颈部鳞状细胞癌基于微环境的新型免疫分子亚群:对免疫治疗的影响。
Ann Oncol. 2019 Jan 1;30(1):68-75. doi: 10.1093/annonc/mdy470.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas.基于 SIRI 的列线图预测鼻咽癌患者临床结局的建立与验证。
J Investig Med. 2019 Mar;67(3):691-698. doi: 10.1136/jim-2018-000801. Epub 2018 Aug 20.
6
The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) Has Prognostic Impact for Survival Outcomes in Nasopharyngeal Carcinoma.结合红细胞分布宽度和体重指数的新型预后评分(COR-BMI)对鼻咽癌生存结局具有预后影响。
J Cancer. 2018 Jun 6;9(13):2295-2301. doi: 10.7150/jca.24838. eCollection 2018.
7
Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.预处理炎症指标可预测野生型 RAS 转移性结直肠癌患者的生存和西妥昔单抗疗效。
Sci Rep. 2017 Dec 7;7(1):17166. doi: 10.1038/s41598-017-17130-6.
8
Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma.化疗联合立体定向放疗治疗鼻咽癌的疗效和安全性。
Med Sci Monit. 2017 Nov 26;23:5630-5636. doi: 10.12659/msm.903903.
9
Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.系统免疫炎症指数预测 III 期非小细胞肺癌患者的放化疗耐药和不良预后。
J Transl Med. 2017 Oct 31;15(1):221. doi: 10.1186/s12967-017-1326-1.
10
Mean Platelet Volume, Red Cell Distribution Width, and Neutrophil-to-Lymphocyte Ratio Before and After Surgery in Patients With Carotid Body Tumors.颈动脉体瘤患者手术前后的平均血小板体积、红细胞分布宽度及中性粒细胞与淋巴细胞比值
J Craniofac Surg. 2017 Oct;28(7):e649-e653. doi: 10.1097/SCS.0000000000003786.